Literature DB >> 24875052

Solid lipid particles for oral delivery of peptide and protein drugs III - the effect of fed state conditions on the in vitro release and degradation of desmopressin.

Philip C Christophersen1, Dimple Vaghela, Anette Müllertz, Mingshi Yang, Hanne M Nielsen, Huiling Mu.   

Abstract

The effect of food intake on the release and degradation of peptide drugs from solid lipid particles is unknown and was therefore investigated in vitro using different fed state media in a lipolysis model. Desmopressin was used as a model peptide and incorporated into solid lipid particles consisting of trimyristin (TG14), tripalmitin (TG16), and tristearin (TG18), respectively. Fasted state and fed state media with varying phospholipid and bile salt concentrations, as well as fed state media with milk and oleic acid glycerides, respectively, were used as the release media. The presence of oleic acid glycerides accelerated the release of desmopressin significantly from all solid lipid particles both in the presence and absence of lipase. The presence of oleic acid glycerides also reduced the degradation rate of desmopressin, probably due to the interactions between the lipids and the protease or desmopressin. Addition of a medium chain triglyceride, trilaurin, in combination with drug-loaded lipid particles diminished the food effect on the TG18 particles, and trilaurin is therefore proposed to be a suitable excipient for reduction of the food effect. Overall, the present study shows that strategies to reduce food effect, such as adding trilaurin, for lipid particle formulations should be considered as drug release from such formulations might be influenced by the presence of food in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24875052      PMCID: PMC4070260          DOI: 10.1208/s12248-014-9619-2

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  27 in total

1.  Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.

Authors:  Na Zhang; Qineng Ping; Guihua Huang; Wenfang Xu; Yanna Cheng; Xiuzhen Han
Journal:  Int J Pharm       Date:  2006-07-21       Impact factor: 5.875

2.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

3.  Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.

Authors:  Pauline De Bruyne; Ann De Guchtenaere; Charlotte Van Herzeele; Ann Raes; Jo Dehoorne; Piet Hoebeke; Erik Van Laecke; Johan Vande Walle
Journal:  Eur J Pediatr       Date:  2013-08-30       Impact factor: 3.183

4.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

5.  Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.

Authors:  S Rittig; A R Jensen; K T Jensen; E B Pedersen
Journal:  Clin Endocrinol (Oxf)       Date:  1998-02       Impact factor: 3.478

6.  Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.

Authors:  Philip Carsten Christophersen; Martin Lau Christiansen; Rene Holm; Jakob Kristensen; Jette Jacobsen; Bertil Abrahamsson; Anette Müllertz
Journal:  Eur J Pharm Sci       Date:  2013-09-18       Impact factor: 4.384

Review 7.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

Authors:  W N Charman; C J Porter; S Mithani; J B Dressman
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

8.  Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats.

Authors:  P J Lowe; C S Temple
Journal:  J Pharm Pharmacol       Date:  1994-07       Impact factor: 3.765

9.  alpha-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins.

Authors:  K Fredholt; J Ostergaard; J Savolainen; G J Friis
Journal:  Int J Pharm       Date:  1999-02-15       Impact factor: 5.875

10.  Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.

Authors:  K Matsui; T Kimura; K Ota; K Iitake; M Shoji; M Inoue; K Yoshinaga
Journal:  Endocrinol Jpn       Date:  1985-08
View more
  2 in total

1.  Synergistic Catalysis by "Polymeric Microzymes and Inorganic Nanozymes": The 1+1>2 Effect for Intramolecular Cyclization of Peptides.

Authors:  Zhiliang Chen; Börje Sellergren; Xiantao Shen
Journal:  Front Chem       Date:  2017-09-26       Impact factor: 5.221

2.  Solid Lipid Microparticles for Oral Delivery of Catalase: Focus on the Protein Structural Integrity and Gastric Protection.

Authors:  Serena Bertoni; Daniele Tedesco; Manuela Bartolini; Cecilia Prata; Nadia Passerini; Beatrice Albertini
Journal:  Mol Pharm       Date:  2020-08-11       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.